AstraZeneca Reaps Fruit From BenevolentAI Deal
Kicks Off With Kidney Disease Candidate
An artificial intelligence and machine learning deal between BenevolentAI and AstraZeneca struck in 2019 has produced its first drug candidate.
An artificial intelligence and machine learning deal between BenevolentAI and AstraZeneca struck in 2019 has produced its first drug candidate.